{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:35:37Z","timestamp":1791214537849,"version":"4.1.0"},"reference-count":46,"publisher":"The Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Context: Prognostic parameters of metastatic adrenocortical carcinoma (ACC) are poorly characterized.<\/jats:p><jats:p>Objective: The objective of the study was to describe the clinical presentation of metastatic ACC and determine prognostic factors for survival.<\/jats:p><jats:p>Design: This was a retrospective cohort study (1988\u20132004).<\/jats:p><jats:p>Setting: The study was conducted in an institutional practice.<\/jats:p><jats:p>Patients: Participants included 124 consecutive patients with metastatic ACC, 70 from Gustave-Roussy Institute (main cohort) and 54 patients from the Cochin Hospital (validation cohort). Clinical data concerning all patients, histopathologic slides of primary tumors (44 in the main cohort and 40 in the validation cohort), and molecular biology data on 15 primary tumors (main cohort) were analyzed.<\/jats:p><jats:p>Intervention: There was no intervention.<\/jats:p><jats:p>Main Outcome: The main outcome was the specific survival after discovery of the first metastasis (Kaplan-Meier method). This included univariate analysis on the main cohort, confirmed on the validation cohort and then analyzed in a multivariate analysis.<\/jats:p><jats:p>Results: In the main cohort, overall median survival was 20 months. In univariate analysis, the presence of hepatic and bone metastases, the number of metastatic lesions and the number of tumoral organs at the time of the first metastasis, a high mitotic rate (&amp;gt;20 per 50 high-power field), and atypical mitoses in the primary tumor predicted survival (P = 0.05, 0.003, 0.046, 0.001, 0.01, and &amp;lt; 0.001, respectively). The number of tumoral organs and a high mitotic rate were confirmed on the validation cohort (P = 0.009 and 0.03, respectively). These two parameters were confirmed in multivariate analysis (P = 0.0058 and 0.049).<\/jats:p><jats:p>Conclusion: Metastatic ACC is a heterogeneous disease with poor outcome. The combination of the number of tumoral organs at the time of the first metastasis and the mitotic rate can predict different outcomes.<\/jats:p>","DOI":"10.1210\/jc.2006-0706","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T03:06:15Z","timestamp":1161745575000},"page":"148-154","source":"Crossref","is-referenced-by-count":197,"title":["Prognostic Parameters of Metastatic Adrenocortical Carcinoma"],"prefix":"10.1210","volume":"92","author":[{"given":"Guillaume","family":"Assie\u0301","sequence":"first","affiliation":[{"name":"Service de Me\u0301decine Nucle\u0301aire et de Cance\u0301rologie Endocrinienne (G.As., S.L., J.-P.T., C.D., M.S., E.B.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillemette","family":"Antoni","sequence":"first","affiliation":[{"name":"De\u0301partement de Sante\u0301 Publique (G.An.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fre\u0301de\u0301rique","family":"Tissier","sequence":"first","affiliation":[{"name":"De\u0301partement d\u2019Anatomo-Pathologie (F.T.), Ho\u0302pital Cochin, Universite\u0301 Paris V Rene\u0301 Descartes, Faculte\u0301 de Me\u0301de\u0301cine, Site Cochin-Port-Royal, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Caillou","sequence":"first","affiliation":[{"name":"De\u0301partement d\u2019Anatomo-Pathologie (B.C.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Abiven","sequence":"first","affiliation":[{"name":"Service d\u2019Endocrinologie (G.Ab., X.B., J.B.), Ho\u0302pital Cochin, Universite\u0301 Paris V Rene\u0301 Descartes, Faculte\u0301 de Me\u0301de\u0301cine, Site Cochin-Port-Royal, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Gicquel","sequence":"first","affiliation":[{"name":"Laboratoire d\u2019Explorations Fonctionnelles Endocriniennes (C.G.), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U-515, Ho\u0302pital Armand Trousseau, Universite\u0301 Paris VI, 75012 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Leboulleux","sequence":"first","affiliation":[{"name":"Service de Me\u0301decine Nucle\u0301aire et de Cance\u0301rologie Endocrinienne (G.As., S.L., J.-P.T., C.D., M.S., E.B.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Travagli","sequence":"first","affiliation":[{"name":"Service de Me\u0301decine Nucle\u0301aire et de Cance\u0301rologie Endocrinienne (G.As., S.L., J.-P.T., C.D., M.S., E.B.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Dromain","sequence":"first","affiliation":[{"name":"Service de Me\u0301decine Nucle\u0301aire et de Cance\u0301rologie Endocrinienne (G.As., S.L., J.-P.T., C.D., M.S., E.B.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bertagna","sequence":"first","affiliation":[{"name":"Service d\u2019Endocrinologie (G.Ab., X.B., J.B.), Ho\u0302pital Cochin, Universite\u0301 Paris V Rene\u0301 Descartes, Faculte\u0301 de Me\u0301de\u0301cine, Site Cochin-Port-Royal, 75014 Paris, France"},{"name":"De\u0301partement Endocrinologie-Me\u0301tabolisme-Cancer (F.T., X.B., J.B.), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U567 and Centre National de la Recherche Scientifique Unite\u0301 Mixte de Recherche 8104, Institut Cochin, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je\u0301ro\u0302me","family":"Bertherat","sequence":"first","affiliation":[{"name":"Service d\u2019Endocrinologie (G.Ab., X.B., J.B.), Ho\u0302pital Cochin, Universite\u0301 Paris V Rene\u0301 Descartes, Faculte\u0301 de Me\u0301de\u0301cine, Site Cochin-Port-Royal, 75014 Paris, France"},{"name":"De\u0301partement Endocrinologie-Me\u0301tabolisme-Cancer (F.T., X.B., J.B.), Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale U567 and Centre National de la Recherche Scientifique Unite\u0301 Mixte de Recherche 8104, Institut Cochin, 75014 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlumberger","sequence":"first","affiliation":[{"name":"Service de Me\u0301decine Nucle\u0301aire et de Cance\u0301rologie Endocrinienne (G.As., S.L., J.-P.T., C.D., M.S., E.B.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"first","affiliation":[{"name":"Service de Me\u0301decine Nucle\u0301aire et de Cance\u0301rologie Endocrinienne (G.As., S.L., J.-P.T., C.D., M.S., E.B.), Institut Gustave-Roussy, Universite\u0301 Paris XI, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613150688400_R1","first-page":"926","article-title":"Adrenal cortical carcinoma\u2014a continuing challenge.","volume":"94","author":"Henley","year":"1983","journal-title":"Surgery"},{"key":"2020071613150688400_R2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/BF02067349","article-title":"Adrenal cortical carcinoma in Norway, 1970\u20131984.","volume":"16","author":"Soreide","year":"1992","journal-title":"World J Surg"},{"key":"2020071613150688400_R3","first-page":"963","article-title":"An eleven-year experience with adrenocortical carcinoma.","volume":"112","author":"Pommier","year":"1992","journal-title":"Surgery"},{"key":"2020071613150688400_R4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","article-title":"Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.","volume":"322","author":"Luton","year":"1990","journal-title":"N Engl J Med"},{"key":"2020071613150688400_R5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0039-6060(96)80164-4","article-title":"The Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. The ACC Italian Registry Study Group.","volume":"119","author":"Crucitti","year":"1996","journal-title":"Surgery"},{"key":"2020071613150688400_R6","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1159\/000227608","article-title":"Adrenocortical carcinoma: experience in 45 patients.","volume":"54","author":"Barzon","year":"1997","journal-title":"Oncology"},{"key":"2020071613150688400_R7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10434-999-0719-7","article-title":"Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma.","volume":"6","author":"Schulick","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"2020071613150688400_R8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","article-title":"Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.","volume":"25","author":"Icard","year":"2001","journal-title":"World J Surg"},{"key":"2020071613150688400_R9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00268-001-0024-5","article-title":"Adrenocortical carcinoma: is prognosis different in nonfunctioning tumors? results of surgical treatment in 31 patients.","volume":"25","author":"Favia","year":"2001","journal-title":"World J Surg"},{"key":"2020071613150688400_R10","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archsurg.136.5.543","article-title":"Adrenocortical carcinoma: surgical progress or status quo?","volume":"136","author":"Kendrick","year":"2001","journal-title":"Arch Surg"},{"key":"2020071613150688400_R11","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/1097-0142(20010901)92:5<1113::AID-CNCR1428>3.0.CO;2-I","article-title":"Adrenocortical carcinoma. Clinical outcome at the end of the 20th century.","volume":"92","author":"Vassilopoulou-Sellin","year":"2001","journal-title":"Cancer"},{"key":"2020071613150688400_R12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.2002.20.4.941","article-title":"Adrenocortical carcinoma: clinical, morphologic, and molecular characterization.","volume":"20","author":"Stojadinovic","year":"2002","journal-title":"J Clin Oncol"},{"key":"2020071613150688400_R13","first-page":"1317","article-title":"Extensive personal experience: adrenocortical tumors.","volume":"82","author":"Latronico","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613150688400_R14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0039-6060(05)80119-9","article-title":"Surgical management, DNA content, and patient survival in adrenal cortical carcinoma.","volume":"118","author":"Lee","year":"1995","journal-title":"Surgery"},{"key":"2020071613150688400_R15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0039-6060(97)90229-4","article-title":"Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma.","volume":"122","author":"Bellantone","year":"1997","journal-title":"Surgery"},{"key":"2020071613150688400_R16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.2930550306","article-title":"Adrenal adenocarcinoma: a review of 53 cases.","volume":"55","author":"Zografos","year":"1994","journal-title":"J Surg Oncol"},{"key":"2020071613150688400_R17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00000478-198903000-00004","article-title":"Pathologic features of prognostic significance in adrenocortical carcinoma.","volume":"13","author":"Weiss","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"2020071613150688400_R18","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/1097-0142(19850215)55:4<766::AID-CNCR2820550414>3.0.CO;2-7","article-title":"Morphologic characteristics of benign and malignant adrenocortical tumors.","volume":"55","author":"Slooten","year":"1985","journal-title":"Cancer"},{"key":"2020071613150688400_R19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0090-4295(00)00852-9","article-title":"Immunohistochemical assessment of Ki-67 in the differential diagnosis of adrenocortical tumors.","volume":"57","author":"Terzolo","year":"2001","journal-title":"Urology"},{"key":"2020071613150688400_R20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1677\/erc.1.01025","article-title":"Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.","volume":"12","author":"Berruti","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"2020071613150688400_R21","first-page":"6762","article-title":"Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.","volume":"61","author":"Gicquel","year":"2001","journal-title":"Cancer Res"},{"key":"2020071613150688400_R22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.134.2.181","article-title":"Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection.","volume":"134","author":"Harrison","year":"1999","journal-title":"Arch Surg"},{"key":"2020071613150688400_R23","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","article-title":"Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.","volume":"72","author":"Wooten","year":"1993","journal-title":"Cancer"},{"key":"2020071613150688400_R24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","article-title":"Adrenocortical carcinoma: clinical and laboratory observations.","volume":"88","author":"Wajchenberg","year":"2000","journal-title":"Cancer"},{"key":"2020071613150688400_R25","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0022-5347(17)57317-6","article-title":"Adrenal cortical carcinoma.","volume":"120","author":"Sullivan","year":"1978","journal-title":"J Urol"},{"key":"2020071613150688400_R26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-5347(17)40734-8","article-title":"The Cleveland Clinic experience with adrenal cortical carcinoma.","volume":"141","author":"Bodie","year":"1989","journal-title":"J Urol"},{"key":"2020071613150688400_R27","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1002\/1097-0142(19910615)67:12<2997::AID-CNCR2820671211>3.0.CO;2-#","article-title":"5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma.","volume":"67","author":"Schlumberger","year":"1991","journal-title":"Cancer"},{"key":"2020071613150688400_R28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/bjc.1998.530","article-title":"Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. Reseau Comete INSERM.","volume":"78","author":"Bonacci","year":"1998","journal-title":"Br J Cancer"},{"key":"2020071613150688400_R29","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/1097-0142(20010915)92:6<1385::AID-CNCR1461>3.0.CO;2-2","article-title":"Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p\u2032DDD) levels on the treatment of patients with adrenocortical carcinoma.","volume":"92","author":"Baudin","year":"2001","journal-title":"Cancer"},{"key":"2020071613150688400_R30","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1210\/jc.2005-2730","article-title":"Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients.","volume":"91","author":"Abiven","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613150688400_R31","first-page":"1444","article-title":"Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.","volume":"78","author":"Gicquel","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613150688400_R32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"2020071613150688400_R33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0021-9681(78)90043-7","article-title":"Estimation of confidence limits for the cumulative probability of survival in life table analysis.","volume":"31","author":"Rothman","year":"1978","journal-title":"J Chronic Dis"},{"key":"2020071613150688400_R34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/bjc.1977.1","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.","volume":"35","author":"Peto","year":"1977","journal-title":"Br J Cancer"},{"key":"2020071613150688400_R35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables.","volume":"34","author":"Cox","year":"1972","journal-title":"J R Statist Soc"},{"key":"2020071613150688400_R36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2265.2003.01881.x","article-title":"Management of adrenocortical carcinoma.","volume":"60","author":"Allolio","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613150688400_R37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00000478-198403000-00001","article-title":"Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors.","volume":"8","author":"Weiss","year":"1984","journal-title":"Am J Surg Pathol"},{"key":"2020071613150688400_R38","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1002\/1097-0142(19800601)45:11<2880::AID-CNCR2820451127>3.0.CO;2-#","article-title":"A clinical and pathological study of adrenocortical carcinoma: therapeutic implications.","volume":"45","author":"Hogan","year":"1980","journal-title":"Cancer"},{"key":"2020071613150688400_R39","first-page":"663","article-title":"Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.","volume":"6","author":"Goldblum","year":"1993","journal-title":"Mod Pathol"},{"key":"2020071613150688400_R40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ajcp\/105.1.76","article-title":"Adrenal cortical neoplasms. A study of 56 cases.","volume":"105","author":"Evans","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"2020071613150688400_R41","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000478-200307000-00001","article-title":"Adrenal cortical neoplasms in the pediatric population: a clinicopathologic and immunophenotypic analysis of 83 patients.","volume":"27","author":"Wieneke","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2020071613150688400_R42","first-page":"2559","article-title":"Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.","volume":"82","author":"Gicquel","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613150688400_R43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0002-9440(10)63846-1","article-title":"Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.","volume":"162","author":"Giordano","year":"2003","journal-title":"Am J Pathol"},{"key":"2020071613150688400_R44","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1210\/jc.2004-1075","article-title":"Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy.","volume":"90","author":"Fraipont","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613150688400_R45","first-page":"4734","article-title":"Expression of the angiogenesis markers vascular endothelial growth factor-A, thrombospondin-1, and platelet-derived endothelial cell growth factor in human sporadic adrenocortical tumors: correlation with genotypic alterations.","volume":"85","author":"Fraipont","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613150688400_R46","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update.","volume":"91","author":"Allolio","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/1\/148\/11059283\/jcem0148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/1\/148\/11059283\/jcem0148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:27:21Z","timestamp":1736616441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/1\/148\/2598258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-0706","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}